Viridian Therapeutics has announced positive topline results from the Phase 3 THRIVE-2 clinical tria...

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued...

eyeDNA Therapeutics, a newly created subsidiary of Coave Therapeutics (‘Coave’), has announced that ...

The European Medicines Agency (EMA) has approved Roche's Vabysmo (faricimab) 6.0 mg single-dose pref...

Atsena Therapeutics has successfully completed dosing in Part A of the LIGHTHOUSE study, a Phase I/I...

Phenocell SAS and Amarna Therapeutics have been awarded the prestigious Eurostars grant to advance t...

ACELYRIN has announced that the Phase 2b/3 clinical trial evaluating izokibep for non-infectious, no...

Tenpoint Therapeutics Ltd. and Visus Therapeutics Inc. have officially merged, combining their respe...

VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, has announced the app...

VisiRose, a newly established company is advancing the development of Rose Bengal Photodynamic Antim...